Werewolf Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Werewolf Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Werewolf Therapeutics Inc
Rating: 1.22266675
Author: Trendlyne DVM scores

about

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...

1.19 0.11 (10.19%)

71.53% Fall from 52W High

705.8K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.7 / 100

Technically Bearish

33.2 / 100

1Yr Price target upside is 698%

6 analysts

Werewolf Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Werewolf Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...

71.53% Fall from 52W High

SWOT Analysis

Werewolf Therapeutics Inc Live Price Chart